ArticleBMC pediatrics2025
Nationwide trends in childhood cancer incidence and survival in Iran: analysis of national cancer registry data, 2005-2014.
Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundChildhood cancer poses a growing global health burden. This study aimed to assess incidence patterns, temporal trends and five-year survival probabilities of childhood cancers in Iran using national cancer registry data from 2005 to 2014.
methodsA retrospective analysis was conducted using data from the Iran National Cancer Registry. After quality control procedures, 20,624 validated cases of childhood cancer (ages 0-14 years) were included. Age-standardized incidence rates (ASIRs) were calculated per million person-years using the new World Health Organization standard population. Trends over time were examined, and five-year observed survival probabilities were estimated for major diagnostic categories according to the International Classification of Childhood Cancer, Third Edition.
resultsThe overall ASIR for childhood cancers in Iran was 116.2 per million person-years, higher in males (128.1) than in females (103.6). The most common cancer groups were leukemia (ASIR: 31.7), lymphomas (ASIR: 13.2), and central nervous system neoplasms (ASIR: 12.6). Lymphoid leukemia was the most frequent subtype (ASIR: 26.6 in males, 20.0 in females). Joinpoint analysis indicated a modest but significant increase in overall ASIRs in both sexes (average annual percent change ≈ 3.5%), driven mainly by central nervous system and hepatic tumors, while retinoblastoma and Hodgkin lymphoma declined. The overall five-year survival was 81.0%, improving from 70.2% in 2005-2009 to 81.4% in 2010-2014. The highest survival was observed in lymphomas (97.1%), followed by retinoblastoma (96.9%), and soft tissue sarcomas (90.7%), while the lowest was found in neuroblastoma (39.1%). Children aged 0-4 years had the lowest survival (79.6%), compared with 82.9% and 82.0% in those aged 5-9 and 10-14 years, respectively.
conclusionsThis nationwide study presents a comprehensive analysis of childhood cancer incidence and survival in Iran. The findings indicate a gradual increase in incidence, particularly among boys and younger children. Survival appears to have improved over time, though variations by age and cancer type warrant cautious interpretation due to differences in follow-up and case mix. These findings highlight progress in pediatric oncology in Iran and underscore the importance of strengthening cancer registration, diagnostic capacity, and equitable access to specialized care to further improve outcomes for children with cancer.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.